ROIV Stock Analysis: Buy, Sell, or Hold?
ROIV - Roivant Sciences Ltd. Common Shares
$26.41
-0.11 (-0.41%)
▼
5d:
-5.44%
30d:
-8.74%
90d:
+18.8%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Feb 16, 2026
0d
Smart Money Accumulation
ROIV is down 4.3% this week, but smart money is accumulating calls. Top strike: $23 2026-05-15 with 7,420 OI. Call ratio: 100% View Scanner →
Strength: 7.1/10
Get Alerted When ROIV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ROIV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ROIV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ROIV is currently trading at $26.41, which is considered oversold relative to its 30-day fair value range of $27.25 to $29.07.
Technical Outlook: Technically, ROIV is in a strong uptrend. The price is currently testing key support at $26.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.25 (+25.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ROIV is in a strong uptrend. The price is currently testing key support at $26.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.25 (+25.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$27.25 -
$29.07
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding ROIV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.9% below Wall St target ($33.25)
- CAUTION: Recommendation downgraded due to -5.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$27.25 -
$29.07
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$26.25
Resistance Level
$28.47
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.60
Wall Street Target
$33.25
(+25.9%)
Revenue Growth (YoY)
-77.8%
Earnings Growth (YoY)
-96.1%
Share & Embed Analysis
Last updated: March 30, 2026 11:50 PM ET
Data refreshes hourly during market hours. Next update: 12:50 AM
Data refreshes hourly during market hours. Next update: 12:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ROIV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Melissa B Epperly
SELL
41861 shares
2026-03-16
Frank Torti
SELL
587390 shares
2026-02-23
Frank Torti
SELL
1012610 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 58 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 67 BUY |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$15 | 56 HOLD |
Advanced ROIV Option Strategies
Professional options setups generated by AI based on today's ROIV price and gamma walls.
